The major surface protein of malaria sporozoites, the circumsporozoite protein, binds to heparan sulfate proteoglycans on the surface of hepatocytes. It has been proposed that this binding event is responsible for the rapid and specific localization of sporozoites to the liver after their injection into the skin by an infected Anopheline mosquito. Previous in vitro studies performed under static
Abstract
The major surface protein of malaria sporozoites, the circumsporozoite protein, binds to heparan sulfate proteoglycans on the surface of hepatocytes. It has been proposed that this binding event is responsible for the rapid and specific localization of sporozoites to the liver after their injection into the skin by an infected Anopheline mosquito. Previous in vitro studies performed under static
conditions have failed to demonstrate a significant role for heparan sulfate proteoglycans during sporozoite invasion of cells. We performed sporozoite attachment and invasion assays under more dynamic conditions and found a dramatic decrease in sporozoite attachment to cells in the presence of heparin.
In contrast to its effect on attachment, heparin does not appear to have an effect on sporozoite invasion of cells. When substituted heparins were used as competitive inhibitors of sporozoite attachment, we found that sulfation of the glycosaminoglycan chains at both the N-and O-positions was important for sporozoite adhesion to cells. We conclude that the binding of the circumsporozoite protein to hepatic heparan sulfate proteoglycans is likely to function during sporozoite attachment in the liver and that this adhesion event depends on the sulfated glycosaminoglycan chains of the proteoglycans.
Introduction
Protozoans of the genus Plasmodium are the causative agents of malaria. In vivo experiments with recombinant CS have shown that intravenously injected protein is rapidly cleared from the circulation by HSPGs of hepatocytes (2, 3) . These results suggest that CS may mediate the rapid clearance of the sporozoites by hepatocytes. In vivo experiments with sporozoites that could prove this point, however, have been difficult to perform. To date, remnant lipoproteins (ligands for hepatic HSPGs) and sulfated glycoconjugates such as fucoidan and dextran sulfate, have been shown to decrease sporozoite infectivity in vivo (3, 4) . However, the inhibitory effect on sporozoite infectivity, while demonstrating that the CS-HSPG interaction is important, does not indicate if the glycan is required for sporozoite attachment, invasion, or subsequent development in hepatocytes.
Malaria infection is initiated when an infected
In vitro assays (5,6) have been used to determine whether the CS-HSPG interaction is critical for cell invasion. Frevert et al. (6) found that removal of the majority of cell surface HSPGs had a minimal inhibitory effect on sporozoite invasion of cells. One interpretation of these data is that the binding of CS to
HSPGs does not function during sporozoite invasion. Another possibility, however, is that CS binding to HSPGs functions in the more dynamic conditions found in the blood circulation and leads to arrest of sporozoites in the liver sinusoids. In this paper we modify the standard sporozoite invasion assay and provide evidence that the interaction between CS and cell surface HSPGs functions during the initial attachment of sporozoites to cells under conditions that mimic flow. In addition, we show that the sulfate moieties of the HSPG glycosaminoglycan chains (GAGs) are important for attachment of sporozoites to cells.
Materials and Methods
Sporozoites and Cell Lines. Plasmodium berghei and Plasmodium yoelii, two species of rodent malaria, were maintained in the laboratory using Anopheles stephensi mosquitoes and mice (7) . Sporozoites were obtained from salivary 6 according to the method of Jaseja et al. (14) ; and carboxyl reduced heparin was made by borohydride reduction in the presence of carbodiimide (15) . 
Results

Heparin is a better inhibitor of sporozoite attachment to cells under conditions that mimic flow.
Previous studies have failed to demonstrate a significant role for HSPGs during sporozoite invasion of cells (6) . Since sporozoites are in the blood circulation when they contact HSPGs in the liver, we reasoned that heparin might be a better inhibitor of sporozoite invasion of cells under conditions that mimic flow. We created shear force between sporozoites in liquid medium and immobilized target cells by placing the experimental chamber on a rotator. We then compared sporozoite attachment to cells in the presence and absence of heparin, under static and rotating conditions. As shown in Figure 1A , heparin is a much more potent inhibitor of sporozoite attachment under rotating conditions compared to static conditions. Inhibition of attachment under rotating conditions is dose-dependent and reaches a maximum of 85% with 25 to 50 µg/ml of heparin ( Fig. 1B) . Under static conditions, increasing the concentration of heparin does not increase its inhibitory activity beyond 15 to 25% (Fig. 1B) .
Importantly, sporozoite attachment to cells is not significantly altered under rotating conditions in the absence of inhibitor (Fig. 1A) .
When the cells with the sporozoites are rotated, the medium moves with respect to the cells which are adherent to the bottom of the wells and a shear force is generated. In a rotating system, however, the shear force is not readily measurable. To circumvent this problem, we performed a sporozoite attachment assay in a parallel plate flow chamber. As shown in Figure 2 , at physiologic shear forces (0.75 to 2 dynes/cm 2 ) heparin is a better inhibitor of sporozoite attachment compared to a very low shear force of 0.25 dynes/cm 2** . Thus, similar results were obtained in both systems.
* we used a very low shear force instead of static conditions because it was technically not feasible to perform a static assay in our flow chamber.
In the experiments shown in Figures 1 and 2 , we did not distinguish between intracellular and extracellular parasites because the cells were permeabilized before the sporozoites were stained. Since sporozoites must attach to cells before entry, we reasoned that attachment occurs by the same mechanism regardless of whether sporozoites have entered the cells. In order to confirm this, we performed the assay in the presence of cytochalasin D, an inhibitor of sporozoite invasion but not attachment (16, 17) . Using a double-staining procedure that enables us to distinguish intracellular from extracellular sporozoites, we found no intracellular sporozoites in the presence of cytochalasin whereas without cytochalasin, the invasion rate was approximately 40% (data not shown). As shown in Figure 3 , cytochalasin-treated sporozoites attached with approximately the same frequency as untreated sporozoites. In addition, the inhibitory effect of heparin on sporozoite attachment was more dramatic under rotating conditions, regardless of whether cytochalasin was present in the medium. It appears, therefore, that sporozoite attachment to cells is a separate, distinguishable phase of cell invasion and that heparin acts on the attachment phase of sporozoite entry into cells.
The CS-HSPG interaction functions during sporozoite attachment to cells.
We then went on to determine the effect of heparin on sporozoite invasion of HepG2 cells under both rotating and static conditions. Results from three experiments indicate that heparin does not have a significant effect on sporozoite invasion of cells (Fig. 4A) . These experiments were performed using a doublestaining procedure that distinguishes between intracellular and extracellular sporozoites and invasion efficiency is expressed as a percentage of total sporozoites bound. Since, as one would expect, the total number of sporozoites bound to cells in the presence of heparin under rotating conditions is low, the absolute number of intracellular sporozoites in these wells is also low. However, the percentage of total sporozoites that are found intracellularly is the same as in the other groups, suggesting that once the sporozoite has attached to the cell, heparin does not affect its ability to enter.
In order to confirm our findings that heparin does not inhibit sporozoite invasion of cells, we used cytochalasin D to separate attachment from invasion of cells. Sporozoites were allowed to attach to cells in the presence of cytochalasin and then the drug was removed. We have found that sporozoites incubated with cytochalasin can, upon its removal, recover from its effects and invade cells (P.
Sinnis unpublished data and Fig. 4C ). Recovery appears to be a stochastic process that begins immediately upon cytochalasin removal and reaches a maximum after approximately 30 minutes. However, only 30 to 50% of the sporozoites recover and are able to invade cells (Fig. 4C ). This is likely because incubation of sporozoites with cytochalasin is performed at 37 o C and it has been shown that sporozoites lose between 60 and 100% of their infectivity after 1 to 2 hours at 37
We performed the cytochalasin recovery experiment under static conditions because our previous data indicated that rotation had no effect on invasion efficiency (Fig. 4A) . As shown in Figure 4C , when heparin was added to the medium after sporozoite attachment to cells, it did not significantly inhibit sporozoite invasion. As expected, sporozoite attachment was the same in all groups because cytochalasin does not inhibit sporozoites from attaching to cells and heparin was added after sporozoite attachment had occured (Fig. 4B ).
When sporozoites were added to the cells in medium without cytochalasin, the invasion rate was two to three fold higher compared to sporozoites that were initially incubated with the cells in the presence of cytochalasin (Fig. 4C ). As stated above, this is likely due to a loss of sporozoite infectivity during the time in which the sporozoites were allowed to attach to but not invade the cells.
The sulfate moieties of HSPGs are critical for CS protein binding to HSPGs.
Previous studies have shown that CS binds to the glycosaminoglycan chains (GAGs) and not the protein core of HSPGs (19) . In addition, CS binds to regions of the GAGs that are more highly sulfated (20, 21) . In order to more precisely into proteoglycans (25) . This is likely also true for HepG2 cells since we found that the sulfate labeled material ran as a high molecular weight smear on SDS-PAGE gel electrophoresis (inset Figure 5) , consistent with its being predominantly composed of proteoglycans. We found no differences in cell growth or protein synthesis in cells incubated in chlorate (data not shown).
We investigated CS binding to chlorate treated cells and found a dosedependent decrease in CS binding (Fig. 6A) . When cells were incubated in medium containing chlorate and an equimolar amount of sulfate, there was no effect on CS binding (inset, Fig. 6A ), suggesting that chlorate is not toxic to the cells and its effect on CS binding is due to its inhibition of sulfation. These studies, taken together with previous results showing that CS binds to HSPGs on the surface of HepG2 cells (6, 19) , suggest that CS binding is correlated with the degree of sulfation of the HSPG GAGs.
In order to determine whether specific sulfate moieties were important for CS To extend these findings and determine whether the requirements for CS binding to cells parallels the requirements for sporozoite attachment, we tested the ability of sporozoites to attach to chlorate-treated HepG2 cells under static and rotating conditions. As shown in Figure 7 , chlorate treatment of HepG2 cells results in a dose dependent decrease in sporozoite attachment and as expected, the effect is much more dramatic under rotating conditions compared to static conditions. Cells incubated with chlorate and an equimolar amount of sulfate showed no inhibition of sporozoite attachment under static or rotating conditions (inset, Fig. 7 ).
We then used the modified heparins as inhibitors of sporozoite attachment to HepG2 cells under rotating conditions. As shown in Figure 8 , heparin that is selectively desulfated in the 2-O and 3-O positions, inhibited sporozoite attachment by only 40% whereas the parent compound inhibited sporozoite attachment by 80%. N-desulfated heparin had similar inhibitory activity to the 2-O, 3-O desulfated compound. When we used heparin that was both N-desulfated and 2-O, 3-O desulfated, the effect was additive and sporozoite adhesion was inhibited by only 20%. The lack of inhibitory activity of the more fully desulfated heparin shows that, similar to CS, sporozoites utilize both types of sulfate groups to bind to HSPGs. Interestingly, the carboxy-reduced heparin inhibited sporozoite attachment by over 50%. This is in contrast to its very low inhibitory activity in the CS protein binding assay. One possible explanation for this discrepancy is that recombinant CS may have sites not exposed on the native protein and these sites may bind to the negatively-charged carboxyl groups of the uronic acids.
Discussion
Previous studies have shown that CS binds to HSPGs [reviewed in (1)].
Although investigators have speculated that this binding event functions in sporozoite attachment to target cells, there is little experimental data to support this hypothesis. Previous in vitro studies failed to demonstrate a significant decrease in sporozoite attachment or invasion using cell lines deficient in HSPGs or cells in which surface HSPGs were removed with heparinase (6) . In the present study, using an inhibitor of the CS-HSPG interaction (heparin), or modifying cell surface HSPGs using chlorate, we significantly inhibit sporozoite attachment to cells under conditions that mimic flow.
Why do the more dynamic conditions of our rotating assay (or the assay performed with a flow chamber) result in a more dramatic inhibition of sporozoite attachment in the presence of heparin compared to the same assay under static conditions? We know from previous studies that only multimers of CS bind with high affinity to HSPGs (26, 27) . Since CS forms a coat on the surface of the sporozoite we can consider the sporozoite to be a very large CS multimer. When heparin is added to the sporozoites, it will bind to many of these CS molecules. It is likely that under static conditions, a low affinity interaction between the sporozoite and the cell is sufficient for parasite attachment so that even in the presence of heparin enough CS will be unoccupied to enable the parasite to attach to the cell. However, the number of unoccupied CS molecules on the sporozoite's surface in the presence of heparin may not be sufficient for the sporozoite to attach to the cell under more dynamic conditions. These results suggest that the multimeric binding between sporozoite CS and hepatic HSPGs may function to arrest the sporozoite in the liver under conditions of flow.
One important consideration, however, is that neither the rotating assay nor the flow chamber is likely to precisely mimic blood flow in the liver. Given the architecture of the liver sinusoids, this is a challenge for any experimental set-up.
However, in both assays, a shear force is created between the medium containing the sporozoites and the immobilized cells. Our experiments therefore allow us to conclude that when shear forces are present, heparin is a more potent inhibitor of sporozoite attachment. The difference between our rotating assay and the parallel plate flow chamber is that in the latter case the flow is more uniform and can be measured. The conclusions we draw from both assays, however, are the same. Although we cannot measure the shear forces in our rotation assay, we think they are in the physiologic range since sporozoites attach well to the cells in this assay and they do not attach to cells when subjected to high shear forces in the flow chamber (data not shown). and glucuronic acid can undergo epimerization to iduronic acid and 2-O sulfation.
These modification reactions are not evenly distributed throughout the chain but tend to occur in blocks, giving rise to highly modified, sulfated stretches of saccharides. In addition, within the modified blocks, these reactions do not occur uniformly so that heparan sulfate GAGs contain a large amount of structural heterogeneity. These modifications can provide specific binding sites for a variety of proteins [reviewed in (28)]. In the case of CS, previous work by Ying et al. (20) found that CS binds preferentially to more highly sulfated regions of HSPG GAGs. We have extended these studies and found that both CS binding and However, endothelial cells themselves express HSPGs on their surface and these could directly compete with hepatic HSPGs for sporozoite binding.
Previous work on the structure of rat liver heparan sulfate has shown that compared to heparan sulfate of other organs, it is more extensively modified and highly sulfated (29) . This is in contrast to endothelial cell heparan sulfate, which is among the most undersulfated heparan sulfate in the body (30) . These findings together with the work presented here, suggest that the degree of GAG chain sulfation, and the architecture of the liver sinusoids, may account for the selective targeting of CS and sporozoites to the liver.
We also present data suggesting that the binding of CS to HSPGs is involved In summary, the work we present here is the first demonstration that the binding of CS on the sporozoite surface to HSPGs functions during initial attachment of the sporozoites to their target cell. Our hypothesis is that the multimeric interaction between sporozoite CS and hepatic HSPGs functions to arrest circulating sporozoites in the liver. Our demonstration that sulfation of HSPG GAGs is required for sporozoite attachment to cells provides a theoretical basis for the selectivity of sporozoites for hepatic HSPGs in vivo. In addition, the data also indicate that initial attachment of sporozoites to hepatic HSPGs is a distinct step in target cell invasion and is likely followed by other molecular interactions that then lead to invasion. The precise nature of these other molecular interactions awaits further investigation. 
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